Vaxxinity, Inc. Class A Common Stock
VAXX
VAXX was delisted on the 8th of May, 2024.
0 hedge funds and large institutions have $0 invested in Vaxxinity, Inc. Class A Common Stock in 2024 Q3 according to their latest regulatory filings, with funds opening new positions, 0 increasing their positions, 0 reducing their positions, and 8 closing their positions.
100% less funds holding
Funds holding: 8 → 0 (-8)
100% less capital invested
Capital invested by funds: $67.8K → $0 (-$67.8K)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 8
Top Buyers
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SWM
Spire Wealth Management
Mclean,
Virginia
|
-$40.4K |
| 2 |
XT
XTX Topco
George Town,
Cayman Islands
|
-$16.7K |
| 3 |
CGL
Clarius Group LLC
Seattle,
Washington
|
-$4.99K |
| 4 |
GT
Glenmede Trust
Philadelphia,
Pennsylvania
|
-$4.78K |
| 5 |
Osaic Holdings
Scottsdale,
Arizona
|
-$596 |
VAXX Hedge Fund Activity: Q3 2024 in Review
0 of the 6,964 institutional investors tracked by Wall St. Rank reported a position in Vaxxinity, Inc. Class A Common Stock (VAXX) for Q3 2024, worth a combined $0 — down 100% from $67.8K a quarter earlier.
Sellers outnumbered buyers: 8 funds closed out of VAXX and 0 opened new positions — a net loss of 8 holders — while 0 trimmed existing stakes and 0 added.
The largest seller was Spire Wealth Management, exiting entirely with an estimated $40.4K sold.
- 0 institutional investors held Vaxxinity, Inc. Class A Common Stock (VAXX) as of Q3 2024, down from 8 in Q2 2024.
- Funds reported $0 of Vaxxinity, Inc. Class A Common Stock stock for Q3 2024, down 100% quarter-over-quarter.
- 0 funds opened new Vaxxinity, Inc. Class A Common Stock positions in Q3 2024 and 8 closed out, a net change of -8 holders.
- The largest Vaxxinity, Inc. Class A Common Stock seller in Q3 2024 was Spire Wealth Management, an estimated $40.4K sold.
Based on aggregated 13F filings for Q3 2024.